Biography
Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France). He was certified by the Federation International of Gynecology Obstetrics (FIGO), the Accreditation Council of Oncology in Europe (ACOE, www.acoe.be), the Institute Catalan of Oncology (ICO) for cervical cancer prevention (Grade 10/10) in support of Continuing Medical Education for physicians. These credits are also recognized as Physician’s Recognition Award (AMA PRA Category 1 credits) by the American Medical Association. He was certified, by the United Nations for Basic Notion of Security on the Ground-Protection, Health and behavior, by the International Agency for Research on Cancer (IARC)/World Health Organization, Lyon (France) for Safety Certificate.
Research Interest
Women genital sphere infections, Cancer, Viruses, Immunology, Pesticides and cancer, Microbiology, Human Bio-banking, Vaccines
Biography
Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra serves as Chief Information Technology Officer and is a member of the Advisory Board at the Kala Institute. He is the COO and Co-founding Partner at The Solomon Brokerage Firm and leads as CEO at Mass Media Division and at De la Parra Mobile Solutions. He is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics. He is the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marekting Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores.
Research Interest
Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development, Nanotechnology, Education Technology, Water Technology and Renewable Energy Technologies.
Biography
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He supervised 121 PhD students, all successfully completed. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic tracheaâ€. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for medical and other industrial applications and synthetic graphene-based nanocomposite materials for surgical and medical devices application. He is currently working on the development of facial organs, heart valves and tendons.
Research Interest
Scientific Activities; Publications